• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Integer Holdings Corporation (Amendment)

    1/30/24 1:15:44 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $ITGR alert in real time by email
    SC 13G/A 1 inte23a1.htm inte23a1.htm - Generated by SEC Publisher for SEC Filing

     

            CUSIP NO.  45826H109                        13G                            Page 1 of 7

     

                                                                                       UNITED STATES

                                                                  SECURITIES AND EXCHANGE COMMISSION

                                                                              Washington, D.C. 20549

     

                                                                                        SCHEDULE 13G

     

                                                           Under the Securities Exchange Act of 1934

                                                                                  (Amendment No. 1)*

     

                                                                        INTEGER HOLDINGS CORPORATION

                                                                                    (Name of Issuer)

     

                                                            Common Stock, $0.001 par value per share

     

                                                                      (Title of Class of Securities)

     

                                                                                           45826H109

                                                                                      (CUSIP Number)

     

                                                                                   December 31, 2023

                                             (Date of Event Which Requires Filing of this Statement)

     

              Check the appropriate box to designate the rule pursuant to which this Schedule is

              filed:

     

              [X] Rule 13d‑1(b)

              [ ] Rule 13d‑1(c)

              [ ] Rule 13d‑1(d)

     

              *The remainder of this cover page shall be filled out for a reporting person's initial

              filing on this form with respect to the subject class of securities, and for any

              subsequent amendment containing information which would alter the disclosures provided

              in a prior cover page.

     

              The information required in the remainder of this cover page shall not be deemed to be

              "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or

              otherwise subject to the liabilities of that section of the Act but shall be subject to

              all other provisions of the Act (however, see the Notes).

     

     


     

     

            CUSIP NO.  45826H109                        13G                            Page 2 of 7

     

              1.   NAMES OF REPORTING PERSONS.    

     

                         Franklin Mutual Advisers, LLC

     

              2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

                         (a)

                         (b) X

     

              3.   SEC USE ONLY

     

              4.   CITIZENSHIP OR PLACE OF ORGANIZATION

     

                         Delaware

     

              NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

     

                         5.   SOLE VOTING POWER

     

                                    (See Item 4)

     

                         6.   SHARED VOTING POWER

     

                                    (See Item 4)

     

                         7.   SOLE DISPOSITIVE POWER

     

                                    (See Item 4)

     

                         8.   SHARED DISPOSITIVE POWER

     

                                    (See Item 4)

     

              9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

                        938,301

     

              10.  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

                         CERTAIN SHARES [ ]

     

              11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

                         2.8%

     

              12.  TYPE OF REPORTING PERSON

     

                         IA, OO (See Item 4)

     

     


     

     

            CUSIP NO.  45826H109                        13G                            Page 3 of 7

     

              Item 1.

     

              (a)   Name of Issuer

     

                          INTEGER HOLDINGS CORPORATION

     

              (b)   Address of Issuer's Principal Executive Offices

     

               5830 Granite Parkway, Suite 1150

               Plano, TX 75024

     

              Item 2.

     

              (a)   Name of Person Filing

     

                          Franklin Mutual Advisers, LLC

     

              (b)   Address of Principal Business Office or, if none, Residence

     

                          101 John F. Kennedy Parkway

                          Short Hills, NJ 07078‑2789

     

              (c)   Citizenship

     

                          Delaware

     

              (d)   Title of Class of Securities

     

                          Common Stock, $0.001 par value per share

     

              (e)   CUSIP Number

     

                          45826H109

     

     


     

     

            CUSIP NO.  45826H109                        13G                            Page 4 of 7

     

              Item 3. If this statement is filed pursuant to §§240.13d‑1(b) or 240.13d‑2(b) or (c),

                              check whether the person filing is a:

                              (a) [ ]  Broker or dealer registered under section 15 of the Act (15 U.S.C. 8o).

     

                              (b) [ ]  Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     

                              (c) [ ]  Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C.

                                                78c).

     

                              (d) [ ]  Investment company registered under section 8 of the Investment Company

                                                Act of 1940 (15 U.S.C 80a ‑8).

     

                              (e) [X]  An investment adviser in accordance with §240.13d‑1(b)(1)(ii)(E);

     

                              (f) [ ]  An employee benefit plan or endowment fund in accordance with

                                                §240.13d‑1(b)(1)(ii)(F);

     

                              (g) [ ]  A parent holding company or control person in accordance with

                                                §240.13d‑1(b)(1)(ii)(G);

     

                              (h) [ ]  A savings associations as defined in Section 3(b) of the Federal

                                                Deposit Insurance Act (12 U.S.C. 1813);

     

                              (i) [ ]  A church plan that is excluded from the definition of an investment

                                                company under section 3(c)(14) of the Investment Company Act of 1940

                                                (15 U.S.C. 80a‑3);

     

                              (j) [ ]  A non‑U.S. institution in accordance with §240.13d‑1(b)(ii)(J);

     

                              (k) [ ]  Group, in accordance with §240.13d‑1(b)(1)(ii)(K).

     

                              If filing as a non‑U.S. institution in accordance with §240.13d‑1(b)(1)(ii)(J),

                              please specify the type of institution

     

     


     

     

            CUSIP NO.  45826H109                        13G                            Page 5 of 7

     

              Item 4. Ownership

     

              The securities reported herein are beneficially owned by one or more open‑end investment

              companies or other managed accounts that are investment management clients of Franklin

              Mutual Advisers, LLC ("FMA"), an indirect wholly owned subsidiary of Franklin Resources,

              Inc. ("FRI"). When an investment management contract (including a sub‑advisory

              agreement) delegates to FMA investment discretion or voting power over the securities

              held in the investment advisory accounts that are subject to that agreement, FRI treats

              FMA as having sole investment discretion or voting authority, as the case may be, unless

              the agreement specifies otherwise. Accordingly, FMA reports on Schedule 13G that it has

              sole investment discretion and voting authority over the securities covered by any such

              investment management agreement, unless otherwise noted in this Item 4. As a result for

              purposes of Rule 13d‑3 under the Act, FMA may be deemed to be the beneficial owner of

              the securities reported in this Schedule 13G.

     

              Beneficial ownership by investment management subsidiaries and other affiliates of FRI

              is being reported in conformity with the guidelines articulated by the SEC staff in

              Release No. 34‑39538 (January 12, 1998) relating to organizations, such as FRI, where

              related entities exercise voting and investment powers over the securities being

              reported independently from each other. The voting and investment powers held by FMA are

              exercised independently from FRI (FMA’s parent holding company) and from all other

              investment management subsidiaries of FRI (FRI, its affiliates and investment management

              subsidiaries other than FMA are, collectively, “FRI affiliates”). Furthermore, internal

              policies and procedures of FMA and FRI affiliates establish informational barriers that

              prevent the flow between FMA and the FRI affiliates of information that relates to the

              voting and investment powers over the securities owned by their respective investment

              management clients. Consequently, FMA and the FRI affiliates report the securities over

              which they hold investment and voting power separately from each other for purposes of

         Section 13 of the Act.

     

              Charles B. Johnson and Rupert H. Johnson, Jr. (the "Principal Shareholders") each own in

              excess of 10% of the outstanding common stock of FRI and are the principal stockholders

              of FRI. However, because FMA exercises voting and investment powers on behalf of its

              investment management clients independently of FRI affiliates, beneficial ownership of

              the securities reported by FMA is not attributed to the Principal Shareholders. FMA

              disclaims any pecuniary interest in any of the securities reported in this Schedule 13G. 

              In addition, the filing of this Schedule 13G on behalf of FMA should not be construed as

              an admission that it is, and it disclaims that it is, the beneficial owner, as defined

              in Rule 13d‑3, of any of such securities.

     

              Furthermore, FMA believes that it is not a "group" with FRI affiliates, the Principal

              Shareholders, or their respective affiliates within the meaning of Rule 13d‑5 under the

              Act and that none of them is otherwise required to attribute to any other the beneficial

              ownership of the securities held by such person or by any persons or entities for whom

              or for which FMA or the FRI affiliates provide investment management

              services.

     

     


     
     

     

            CUSIP NO.  45826H109                        13G                            Page 6 of 7

     

                  (a)    Amount beneficially owned:

     

                               938,301

                  (b)    Percent of class:

     

                                2.8%

     

                  (c)    Number of shares as to which the person has:

     

                          (i)   Sole power to vote or to direct the vote

     

                                        Franklin Mutual Advisers, LLC:                                  881,985

     

                        (ii)   Shared power to vote or to direct the vote

     

                                        0

     

                      (iii)   Sole power to dispose or to direct the disposition of

     

                                        Franklin Mutual Advisers, LLC:                                  938,301

     

                        (iv)   Shared power to dispose or to direct the disposition of

     

                                        0

     

              Item 5.  Ownership of Five Percent or Less of a Class

     

                                If this statement is being filed to report the fact that as of the date hereof

                                the reporting person has ceased to be the beneficial owner of more than five

                                percent of the class of securities, check the following [X]. 

     

              Item 6.  Ownership of More than Five Percent on Behalf of Another Person

     

                                The clients of Franklin Mutual Advisers, LLC, including investment companies

                                registered under the Investment Company Act of 1940 and other managed accounts,

                                have the right to receive or power to direct the receipt of dividends from, and

                                the proceeds from the sale of, the securities reported herein.

     

     

     

              Item 7. Identification and Classification of the Subsidiary Which Acquired the

                              Security Being Reported on By the Parent Holding Company

     

                              Not Applicable

     

              Item 8. Identification and Classification of Members of the Group

     

                              Not Applicable

     

              Item 9. Notice of Dissolution of Group

     

                              Not Applicable

     

     


     
     

     

            CUSIP NO.  45826H109                        13G                            Page 7 of 7

     

              Item 10. Certification

     

              By signing below I certify that, to the best of my knowledge and belief, the securities

              referred to above were acquired and are held in the ordinary course of business and were

              not acquired and are not held for the purpose of or with the effect of changing or

              influencing the control of the issuer of the securities and were not acquired and are

              not held in connection with or as a participant in any transaction having that purpose

              or effect, other than activities solely in connection with a nomination under §

              240.14a‑11.

     

             

     

                                                                                      SIGNATURE

     

              After reasonable inquiry and to the best of my knowledge and belief, I certify that the

              information set forth in this statement is true, complete and correct.

     

              Dated:      January 23, 2024

     

              Franklin Mutual Advisers, LLC

               

     

                By:    /s/VIRGINIA E. ROSAS

                              ‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑

                              Virginia E. Rosas

                              Secretary of Franklin Mutual Advisers, LLC

     

    Get the next $ITGR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ITGR

    DatePrice TargetRatingAnalyst
    10/24/2025Buy → Hold
    Argus
    10/24/2025$80.00Overweight → Equal Weight
    Wells Fargo
    10/24/2025$77.00Buy → Neutral
    Citigroup
    10/24/2025$87.00Buy → Neutral
    BofA Securities
    10/24/2025Buy → Hold
    The Benchmark Company
    5/22/2025$140.00Neutral → Buy
    Citigroup
    3/28/2025$145.00Outperform
    Raymond James
    2/21/2025Outperform → Perform
    Oppenheimer
    More analyst ratings

    $ITGR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Integer Holdings downgraded by Argus

    Argus downgraded Integer Holdings from Buy to Hold

    10/24/25 2:15:30 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Integer Holdings downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Integer Holdings from Overweight to Equal Weight and set a new price target of $80.00

    10/24/25 8:57:52 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Integer Holdings downgraded by Citigroup with a new price target

    Citigroup downgraded Integer Holdings from Buy to Neutral and set a new price target of $77.00

    10/24/25 8:57:52 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITGR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Financial Officer Smith Diron bought $74,967 worth of shares (1,116 units at $67.19), increasing direct ownership by 17% to 7,698 units (SEC Form 4)

    4 - Integer Holdings Corp (0001114483) (Issuer)

    11/10/25 8:19:02 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Capps Cheryl C bought $106,720 worth of shares (1,600 units at $66.70), increasing direct ownership by 16% to 11,702 units (SEC Form 4)

    4 - Integer Holdings Corp (0001114483) (Issuer)

    11/10/25 8:16:21 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    President & CEO Khales Payman bought $203,067 worth of shares (3,127 units at $64.94), increasing direct ownership by 16% to 22,865 units (SEC Form 4)

    4 - Integer Holdings Corp (0001114483) (Issuer)

    10/30/25 4:05:07 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITGR
    SEC Filings

    View All

    Integer Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Integer Holdings Corp (0001114483) (Filer)

    11/4/25 8:01:46 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Integer Holdings Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Integer Holdings Corp (0001114483) (Filer)

    10/24/25 8:01:29 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form 10-Q/A filed by Integer Holdings Corporation

    10-Q/A - Integer Holdings Corp (0001114483) (Filer)

    10/24/25 7:36:36 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITGR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Integer Holdings Corporation Board Authorizes $200 Million Share Repurchase Program

    PLANO, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device contract development and manufacturing organization, today announced that its Board of Directors has authorized a share repurchase program of up to $200 million of the Company's outstanding common stock. "This share repurchase program reflects the confidence of the Board and management in our strategy, financial position, and ability to generate strong free cash flows," said Payman Khales, Integer's president and CEO. The Company intends to primarily utilize cash on hand and free cash flows to fund the share repurchase program. The timing and volume of share repurchases may

    11/4/25 8:00:00 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Payman Khales Assumes Role as Integer President and CEO

    ~ Planned Leadership Transition Completed ~ PLANO, Texas, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today shared that, as part of a planned transition originally announced in April 2025, Payman Khales has assumed the role of President and Chief Executive Officer. He also joins the company's Board of Directors. He succeeds Joseph Dziedzic, who is retiring after eight years of distinguished service as Integer President and CEO and will continue to serve as an advisor through March 31, 2026, to support a smooth transition. Mr. Khales joined Integer in 2018 as Preside

    10/24/25 8:00:00 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Integer Holdings Corporation Reports Third Quarter 2025 Results

    ~ Continued strong sales and profit growth in 3Q25 ~~ Updating 2025 sales and profit outlook; providing preliminary outlooks for 2026 and 2027 ~ PLANO, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended September 26, 2025. Third Quarter 2025 Highlights (compared to Third Quarter 2024, except as noted) Sales increased 8% to $468 million, with organic growth of 7%.GAAP operating income decreased $2 million to $56 million, a decrease of 3%. Non-GAAP adjusted operating income increased $10 million to $86 million, an increase of 14%.GAAP income from continuing operations increased $3 million to $40 million, an

    10/23/25 8:00:00 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITGR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Financial Officer Smith Diron bought $74,967 worth of shares (1,116 units at $67.19), increasing direct ownership by 17% to 7,698 units (SEC Form 4)

    4 - Integer Holdings Corp (0001114483) (Issuer)

    11/10/25 8:19:02 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Capps Cheryl C bought $106,720 worth of shares (1,600 units at $66.70), increasing direct ownership by 16% to 11,702 units (SEC Form 4)

    4 - Integer Holdings Corp (0001114483) (Issuer)

    11/10/25 8:16:21 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    President & CEO Khales Payman bought $203,067 worth of shares (3,127 units at $64.94), increasing direct ownership by 16% to 22,865 units (SEC Form 4)

    4 - Integer Holdings Corp (0001114483) (Issuer)

    10/30/25 4:05:07 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITGR
    Leadership Updates

    Live Leadership Updates

    View All

    Payman Khales Assumes Role as Integer President and CEO

    ~ Planned Leadership Transition Completed ~ PLANO, Texas, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today shared that, as part of a planned transition originally announced in April 2025, Payman Khales has assumed the role of President and Chief Executive Officer. He also joins the company's Board of Directors. He succeeds Joseph Dziedzic, who is retiring after eight years of distinguished service as Integer President and CEO and will continue to serve as an advisor through March 31, 2026, to support a smooth transition. Mr. Khales joined Integer in 2018 as Preside

    10/24/25 8:00:00 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Integer Appoints Michael Coyle to Board of Directors

    ~ New Director Brings Extensive Medical Device Industry Leadership and Technology Experience to Integer Board ~ PLANO, Texas, July 10, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced it has appointed Michael Coyle to its Board of Directors. Coyle brings more than 40 years of leadership in the medical device industry to Integer and joins the Board as a member of the Audit Committee, Compensation & Organization Committee, and Technology Strategy Committee. He most recently served as president and CEO of iRhythm Technologies, a digital healthcare company. Bef

    7/10/25 4:52:01 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Eargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority Shareholder

    SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors following the closing of the Company's rights offering as previously announced on November 29, 2022. Patient Square Capital became the Company's majority owner upon closing of the rights offering and conversion of Patient Square's senior secured convertible notes per its investment in June 2022. As previously announced, following the completion of the rights offering, Patient Square has the right to nominate a number of directors t

    12/7/22 4:05:00 PM ET
    $EAR
    $ITGR
    $VAPO
    Medical Specialities
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    $ITGR
    Financials

    Live finance-specific insights

    View All

    Integer Holdings Corporation Reports Third Quarter 2025 Results

    ~ Continued strong sales and profit growth in 3Q25 ~~ Updating 2025 sales and profit outlook; providing preliminary outlooks for 2026 and 2027 ~ PLANO, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended September 26, 2025. Third Quarter 2025 Highlights (compared to Third Quarter 2024, except as noted) Sales increased 8% to $468 million, with organic growth of 7%.GAAP operating income decreased $2 million to $56 million, a decrease of 3%. Non-GAAP adjusted operating income increased $10 million to $86 million, an increase of 14%.GAAP income from continuing operations increased $3 million to $40 million, an

    10/23/25 8:00:00 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Integer Announces Conference Call to Discuss Third Quarter 2025 Results

    PLANO, Texas, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights for the third quarter ended Sept. 26, 2025, on Thursday, Oct. 23, 2025, at 8 a.m. CT / 9 a.m. ET. Other forward-looking and material information may also be discussed during this call. The company will issue a news release announcing financial results for the third quarter on Oct. 23 prior to the conference call. Conference call details: Date: Thursday, Oct. 23, 2025Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 3

    9/25/25 8:00:00 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Integer Holdings Corporation Reports Second Quarter 2025 Results

    ~ Continued strong sales and profit growth in 2Q25 ~ ~ Raising 2025 full year adjusted operating income and EPS outlook midpoint ~ PLANO, Texas, July 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended June 27, 2025. Second Quarter 2025 Highlights (compared to Second Quarter 2024, except as noted) Sales increased 11% to $476 million, with organic growth of 11%.GAAP operating income increased $5 million to $59 million, an increase of 9%. Non-GAAP adjusted operating income increased $10 million to $81 million, an increase of 15%.GAAP income from continuing operations increased $6 million to $37 m

    7/24/25 8:00:00 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITGR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Integer Holdings Corporation (Amendment)

    SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

    2/9/24 9:59:01 AM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by Integer Holdings Corporation (Amendment)

    SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

    1/30/24 1:15:44 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by Integer Holdings Corporation (Amendment)

    SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

    2/10/23 2:42:23 PM ET
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care